Literature Citations
1. Synthesis and Antimycobacterial Activity of Some New Pyrazinamide Derivatives. Almehmadi, M., M. Halawi, and M. Asif. Pharmaceutical Chemistry Journal, 2022. 56: p. 456-460. ISI[000823407000002].
[WOS]. TB_07_2022.
2. The Discovery of Penta-peptides Inhibiting the Activity of the Formylglycine-generating Enzyme and Their Potential Antibacterial Effects against Mycobacterium tuberculosis. Asiimwe, N., M.F. Al Mazid, Y.T. Jeong, J. Lee, and J.S. Lee. RSC Advances, 2022. 12(29): p. 18884-18888. PMID[35873338]. PMCID[PMC9241360].
[PubMed]. TB_07_2022.
3. Synthesis of Hydrazides of Heterocyclic Amines and their Antimicrobial and Spasmolytic Activity. Berillo, D.A. and M.A. Dyusebaeva. Saudi Pharmaceutical Journal, 2022. 30(7): p. 1036-1043. PMID[35903529]. PMID[PMC9315279].
[PubMed]. TB_07_2022.
4. In Vitro Activity of Rifabutin against Mycobacterium abscessus, Clinical Isolates. Chen, J., H. Zhang, Q. Guo, S. He, L. Xu, Z. Zhang, J. Ma, and H. Chu. Clinical and Experimental Pharmacology and Physiology, 2022. 49(7): p. 767-775. PMID[35531776].
[PubMed]. TB_07_2022.
5. An Antibacterial Compound Pyrimidomycin Produced by Streptomyces sp. psaa01 Isolated from Soil of Eastern Himalayan Foothill. Das, P., S. Kundu, P.K. Maiti, S. Mandal, P. Sahoo, and S. Mandal. Scientific Reports, 2022. 12(1): p. 10176. PMID[35715695]. PMID[PMC9206078].
[PubMed]. TB_07_2022.
6. Antimycobacterial, Cytotoxic, and Anti-inflammatory Activities of Artemisialudoviciana. Gálvez Romero, J.L., C.M. Parada Sosa, G.L. Burgoa, A.C. Lorenzo Leal, E.G. El Kassis, E. Bautista Rodríguez, G.A. Paredes Juárez, L.R. Hernández, H. Bach, and Z.N. Juárez. Journal of Ethnopharmacology, 2022. 293: 115249. PMID[35395382].
[PubMed]. TB_07_2022.
7. Syntheses, Structural Characterization and Evaluation of the Anti-tubercular Activity of Copper (II) Complexes Containing 3-Methoxysalicylaldehyde-4-methylthiosemicarbazone. Hegde, P.L., S.S. Bhat, V.K. Revankar, S.A. Shaikh, K. Kumara, and N.K. Lokanath. Journal of Molecular Structure, 2022. 1257: 132589. ISI[000820971000012].
[WOS]. TB_07_2022.
8. In Vitro Assessment of 17 Antimicrobial Agents against Clinical Mycobacterium avium Complex Isolates. Lin, S., W. Hua, S. Wang, Y. Zhang, X. Chen, H. Liu, L. Shao, J. Chen, and W. Zhang. BMC Microbiology, 2022. 22(1): 175. PMID[35804298]. PMID[PMC9264595].
[PubMed]. TB_07_2022.
9. Pyridine Appended 2-hydrazinylthiazole Derivatives: Design, Synthesis, in Vitro and in Silico Antimycobacterial Studies. Matsa, R., P. Makam, G. Sethi, A.A. Thottasseri, A.R. Kizhakkandiyil, K. Ramadas, V. Mariappan, A.B. Pillai, and T. Kannan. RSC Advances, 2022. 12(29): p. 18333-18346. PMID[35799934]. PMCID[PMC9215125].
[PubMed]. TB_07_2022.
10. Susceptibility of beta-Lactam Antibiotics and Genetic Mutation of Drug-Resistant Mycobacterium Tuberculosis Isolates in Korea. Park, S., J. Jung, J. Kim, S.B. Han, and S. Ryoo. Tuberculosis and respiratory diseases, 2022. 85(3): p. 256-263. PMID[35586904]. PMID[PMC9263340].
[PubMed]. TB_07_2022.
11. Synthesis and Evaluation of Marine Natural Product-inspired Meroterpenoids with Selective Activity toward Dormant Mycobacterium tuberculosis. Si, A., A.D. Landgraf, S. Geden, S.J. Sucheck, and K.H. Rohde. ACS Omega, 2022. 7(27): p. 23487-23496. PMID[35847331]. PMID[PMC9281309].
[PubMed]. TB_07_2022.
Patent Citations
12. Rifamycin Analogs as Antibacterial Agents and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Tuberculosis. Garcia, G., H. Showalter, W. Rajeswaran, P. Lee, S. Franzblau, and K. Murakami. Patent. 2022. 2022-US12980 2022159491: 141pp.
[Patent]. TB_07_2022.
13. Heteroaromatic Compounds as Inhibitors of Mycobacterium tuberculosis Lipoamide dehydrogenase and Their Preparation. Ginn, J., S. Sun, M. Michino, N. Liverton, R. Liang, P.T. Meinke, D. Huggins, R. Bryk, and C.F. Nathan. Patent. 2022. 2022-US11588 2022150574: 418pp.
[Patent]. TB_07_2022.